Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Spectrum Plasma Receives 2026 Global Recognition Award
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITISH LAND CO PLC - Ordinary Shares
-
Klarna Expands Its Partnership With H&M in Romania and Hungary
-
20 years of the UN Human Rights Council: No civilian should ever become casualties of conflict
-
Notice to convene Annual General Meeting
-
The Barton Partnership Expands North American Leadership Offering with the Appointment of Marty O'Doherty and Purab Parikh
-
First Mold Releases Technical White Paper Revealing That the Majority of Injection Molding Defects Originate in the Design Phase
-
Recyclable Packaging and Responsible Water Management: Barilla’s Commitment to a More Sustainable Future
-
West Red Lake Gold Added To GDXJ Junior Gold Miners ETF
-
Philips convenes the Annual General Meeting of Shareholders 2026
-
Antea Group UK Sponsors 2026 AWS Global Water Stewardship Forum Through Inogen Alliance
-
The Great Repricing of Plastic: How Recycling is Moving from ESG Narrative to Economic Reality
-
Replacement in bonds for new lending - Nykredit Realkredit A/S
-
PEI Group Acquires Scientific Infra & Private Assets (SIPA) to Accelerate Innovation in Private Markets Analytics
-
Abselion Appoints Dale Gordon as Chair
-
Massive Gaming Secures MGA B2B License to Expand Global iGaming Partnerships
-
Annual Report 2025
-
InvisALERT Solutions Advances Patient and Staff Safety Through AI‑Driven Innovation
-
Lung Cancer Survivors and Advocates Head to Capitol Hill to Champion Lifesaving Research, Prevention and Access to Care
-
20/2026・Trifork Group: Weekly report on share buyback
-
Oryon Cell Therapies Reports Phase 1b/2a Data Showing Sustained Motor Improvements in People with Parkinson’s Disease
-
FastBlast Smoothie Expands U.S. Distribution with Amazon Availability
-
Oryon Cell Therapies Emerges From Stealth Focusing on Autologous Neuron Replacement Therapies for Parkinson’s Disease and Other Neurodegenerative Disorders
-
Best Primary Care Membership (2026): MDVIP Named Top Preventive Health Program by Expert Consumers
-
Berkshire Hathaway Specialty Insurance Launches Executive First D&O Liability Insurance Policies in Switzerland
-
FICO UK Credit Card Market Report: January 2026
-
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
-
Form 8.3 - [
-
Danske Bank share buy-back programme: transactions in week 12
-
Karsan Targets the Top 5 in Europe with Its Innovative Products and High-Tech Solutions
-
Proofpoint Redefines Email and Data Security for the Agentic Workspace
-
Transactions in connection with share buyback programme
-
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning
-
Spiritual Medium Cheryl Bradley Announces the Release of Her First Book, A Spirit's Journey, Arriving March 23, 2026
-
AEM and ASE Enter Strategic Partnership to Accelerate AI and HPC Test Innovation
-
Prepayments, Realkredit Danmark A/S
-
LTM Expands BlueVerse™ Tech with AppIQ, AgentIQ and FusionIQ to Accelerate AI‑Led Engineering
-
Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
-
BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns
-
Alm. Brand A/S share buy-back program is concluded - transactions week 12
-
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment
-
UK Healthy Snacks Market to Reach USD 28.17 Billion by 2032, Driven by Rising Demand for Free-From and Functional Nutrition, Reports Vyansa Intelligence
-
PR Newswire Expands UK Reach, Adds 65 Exclusive New Websites
-
Toobit Joins Crypto Summit 2026 as Strategic Partner
-
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning
-
Hitachi Receives the 2026 Catalyst Award, a Global Recognition for Building an Inclusive Organization
-
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
-
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
-
Columbus – Weekly report on share buyback
